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To study  the post-treatment  effects  of  dietary  curcumin  on  the levels  of benzo(a)pyrene
[B(a)P]-induced  DNA  adducts,  mice  were  administered  oil or B(a)P  and  randomized  into  7
subgroups  after  24  h. One  of the  subgroups  from  both  the  oil and B(a)P  groups  was  killed  at
24 h while  the  remaining  6  subgroups  were  shifted  to powdered  control  or 0.05%  curcumin
diet  and  killed  after  24, 72  and  120 h (experiment  1),  and  7, 14, and  28  days  (experi-
ment  2).  Quantitative  comparisons  of BPDE-DNA  nuclear  adducts  (area  and  intensity)  in
immunohistochemically  stained  lungs  and  liver sections  was  carried  out  by IHC  proﬁler.  A
time-dependent  decrease  in  the  levels  of adducts  in B(a)P-treated  animals  was  further
enhanced  by curcumin  exposure  compared  to  the  levels  in  time-matched  controls.  To
assess  the  contribution  of  apoptosis  and  cell proliferation  in observed  curcumin-mediated
enhanced  decrease  of  BPDE-DNA  adducts,  comparative  evaluation  of apoptosis  and  cell
proliferation  markers  was  undertaken.  Results  suggested  enhancement  of  B(a)P-induced
apoptosis  in liver  and  lungs  by curcumin  during  24–120  h  while  no  such  enhancement
was  observed  at  7–28  days.  Results  suggest  curcumin-mediated  enhancement  in apoptosis
(experiment 1) and  adduct  dilution  (experiment  2)  to  be  the  reason  for the  observed  higher
decrease  of BPDE-DNA  adducts.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).Abbreviations: B(a)P, benzo(a)pyrene; BPDE, benzo(a)pyrenediol-
poxide;  CYP450, cytochrome P450; HRP, horseradish peroxidase; IHC,
mmunohistochemical; PAH, polycyclic aromatic hydrocarbons; PVDF,
olyvinylidene diﬂuoride; TBS, tris-buffered saline; TBST, TBS containing
.1% Tween-20.
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Polycyclic aromatic hydrocarbons (PAH) are ubiqui-
tous environmental agents, many of which have been
identiﬁed as toxic, mutagenic and/or potent human car-
cinogens [1,2]. PAH occur widely in the environment as a
result  of incomplete combustion of fossil fuels and other
organic matter, and human exposure to PAH is there-
fore unavoidable [3]. Humans are exposed to complex
mixtures of PAH, which have been implicated in induc-
ing  skin, lung and breast cancer. Benzo(a)pyrene [B(a)P],
a  well-known ubiquitous carcinogen belonging to the
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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PAH group of compounds, is metabolically activated by
phase  I enzymes [or CYP1A class of cytochrome P450
(CYP450) enzymes] to form a highly mutagenic reactive
electrophile, benzo(a)pyrenediol-epoxide (BPDE). Though
phase  II enzymes catalyze the detoxiﬁcation of BPDE,
some of the reactive electrophiles interact covalently with
DNA  to form adducts that mark an early initiation event.
Unrepaired/misrepaired adducts lead to mutation in genes
involved  in proliferation, growth, apoptosis and ﬁnally to a
disease  condition such as cancer [4].
Plant-derived natural compounds have been receiving
increased attention as chemopreventives because of their
low  toxicity and high tolerability. The efﬁcacy of polyphe-
nols  when administered before or after the carcinogen
treatment has been established and shown to mod-
ulate carcinogen-induced incidence/multiplicity/latency
period of tumor development [5]. Curcumin/turmeric has
been  shown to possess chemopreventive activity at both
initiation  and promotion stages of chemical-induced car-
cinogenesis [6–10]. Earlier studies have shown that dietary
curcumin pre-treatment decreases the formation of B(a)P-
derived  DNA adducts in mouse tissues by inhibiting
carcinogen-induced phase I enzymes and directly induc-
ing  phase II enzymes [7]. Effects of turmeric/curcumin
after exposure to carcinogens on the repair or disappear-
ance of adducts, if any, are not known. Hence, in the
present study, the post-treatment effect of curcumin on
the  disappearance of BPDE-DNA adducts in tissues of mice
have  been evaluated. Herein, we show that dietary cur-
cumin  treatment subsequent to B(a)P exposure enhances
the  disappearance of BPDE-DNA adducts. This could pos-
sibly  be due to the curcumin-mediated enhancement of
apoptosis  of DNA adduct-containing cells and/or repair of
DNA-adducts in mouse tissues.
2. Materials and methods
2.1.  Materials
Benzo(a)pyrene [B(a)P] (purity ∼98%) and curcumin
(purity ∼65–70%) were obtained from Sigma–Aldrich (St.
Louis,  MO,  USA). Antibodies for Bax, Bcl-2, cyclin D1,
-actin, anti-mouse horseradish peroxidase (HRP) conju-
gated  secondary antibodies were purchased from Santa
Cruz  Biotechnology (Santa Cruz, CA, USA) and caspase-3
from Abcam (Cambridge, MA,  USA). Monoclonal antibody
for  BPDE-DNA adduct clone 5D11 was obtained from
Hycult Biotechnology (Uden, Netherlands). The mono-
clonal antibody for proliferating cell nuclear antigen
(PCNA) was procured from BD Pharmingen (San Diego, CA,
USA).  The anti-rabbit HRP conjugated secondary antibodies
were  obtained from Amersham Biosciences (Bucking-
hamshire, UK).
2.2.  Animal treatment
All  animal studies were conducted with approval from
the  Institutional Animal Ethics Committee endorsed by
the  Committee for the Purpose of Control and Supervi-
sion of Experiments on Animals (CPCSEA), Government of
India  guidelines. Inbred male Swiss albino mice (6–8 weekrts 1 (2014) 1181–1194
old;  Animal house, ACTREC, India) were randomized and
housed  in polypropylene cages, maintained under standard
conditions of 22 ± 2 ◦C, 50% ± 10% relative humidity, and
12  h light/dark cycles. They received a control/experiment
diet and drinking water ad libitum during the experimen-
tal period. Two different sets of experiments (1 and 2) were
conducted at different times. Initially, corn oil (0.1 ml, V
group)  or B(a)P (1 mg  in 0.1 ml  corn oil, BP group) was
administered by gavage to all animals that were main-
tained on standard laboratory diet (Fig. 1). After 24 h of
corn  oil or B(a)P administration, mice were randomized
into seven subgroups. One of the subgroups (from both the
groups  V and BP) was killed at 24 h time point [subgroups
V(+24 h) and BP(+24 h)] whereas half of the 6 subgroups (from
both the groups) were continued on the powdered con-
trol  diet (standard laboratory diet) and the other half were
shifted  to powdered experimental diet (0.05% curcumin in
standard  laboratory diet), which was  prepared as described
[11].  In experiment 1, mice shifted to control/experimental
diets were killed after 24, 72 and 120 h [BP(+48 h), BP(+96 h),
BP(+144 h) (control diet)/BP(+48 h) + C 24 h, BP(+96 h) + C 72 h,
BP(+144 h) + C 120 h (experimental diet)] whereas in exper-
iment 2, they were killed after 7, 14 and 28 days [BP(+8 d),
BP(+15 d), BP(+29 d) (control diet)/BP(+8 d) + C 7 d, BP(+15 d) + C
14 d, BP(+29 d) + C 28 d (experimental diet)]. Both the experi-
ments 1 and 2 had independent V(+24 h) and BP(+24 h) groups.
Animals in all subgroups were observed for any apparent
signs of toxicity such as weight loss or mortality dur-
ing  the entire study period. Animals were killed by CO2
asphyxiation and their liver and lungs were perfused and
excised,  and a part of the liver and lungs tissue were ﬁxed in
10%  buffered formalin for histopathological evaluation and
immunohistochemical (IHC) staining, while the rest of the
tissues  were snap frozen in liquid nitrogen and stored at
−80 ◦C until preparation of extract. The experimental con-
ditions, i.e. dose, route of B(a)P administration, sampling
time, dose and route of curcumin exposure employed in the
present  study, were chosen on the basis of our earlier stud-
ies  demonstrating the effect of curcumin on the formation
of  BPDE-DNA adducts in mouse liver and lungs [7,12].
2.3.  Protein immunoblotting
Total  cell lysates from the tissues were prepared by
previously described cell fractionation procedure [13]. The
lysates  were aliquoted, their protein content was deter-
mined, and they were stored at −80 ◦C. The total cell
proteins (50–100 g) were resolved on 8–12% sodium-
dodecylsulphate polyacrylamide gel and transferred to a
polyvinylidene diﬂuoride (PVDF) membrane. After block-
ing  with 5% non-fat skimmed milk in Tris-buffered
saline (TBS, pH 7.4) containing 0.1% Tween-20 (TBST),
the  membranes were probed with antibodies for Bax,
Bcl-2, caspase-3, PCNA, cyclin D1 overnight at 4 ◦C.
All  primary and secondary antibodies were ﬁrst stan-
dardized for their dilution and then used accordingly.
Blotting membranes were then washed three times with
TBST  and incubated with 1:4000 dilutions of anti-rabbit,
anti-mouse, or anti-goat HRP conjugated secondary anti-
bodies.  Immunoreactive bands were visualized using
a  chemiluminescence reagent (Amersham Biosciences,
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uckinghamshire, UK), followed by autoradiography. -
ctin  was used as the loading control. Densitometry of
arious  analyte proteins and their respective loading con-
rols  from the same blot was performed using Image J 1.43
NIH)  software. Relative optical density was calculated by
ividing  the densitometry of analyte(s) protein with the
espective loading control.
.4.  BPDE-DNA adduct measurement
The levels of BPDE-DNA adducts were detected by
mmunohistochemical staining for BPDE-DNA adducts in
ormalin-ﬁxed, parafﬁn embedded 5 m tissue sections as
escribed  previously [14]. Sections were incubated with
nti-BPDE antibody (1:30 dilution). Detection was done
sing  Vectastain ABC kit (Vector Laboratories, Burlingame,
A,  USA). Diaminobenzidine (DAB) was employed as the
hromogenic substrate, and slides were counterstained
ith Mayer’s hematoxylin. Images were captured with
eiss  Microscope (Imager Z1) to which an Axiocam MRc5
igital  camera was attached. Quantitative analysis of
he  images (magniﬁcation ×400) was performed by IHCtment on disappearance of BPDE-DNA adducts in mouse tissues.
proﬁler  [15], which is an open source plug-in for the
quantitative evaluation and automated scoring of immuno-
histochemistry images of tissue samples. This modiﬁed
digital image analysis is based on protocols adopted earlier
[16].
2.5.  Digital image analysis
IHC  photomicrographs were used for developing semi-
automated analysis protocol, namely IHC proﬁler [15].
As  a ﬁrst step, a color de-convolution plug-in was  used
to  un-mix the pure DAB and hematoxylin stained areas
that  left a complimentary image. The pixel intensities
of separated DAB images range from 0 to 255. Value
0  represents the darkest shade whereas 255 represents
the lightest shade of the DAB brown color in the image.
To  select the DAB-stained (brown) nuclei, the thresh-
old feature of the Image J 1.43 (NIH) software was used.
Further to assign an automated percentage of pure DAB
staining patterns in the nucleus, a macro was  devel-
oped and plugged in the Image J 1.43 (NIH) software to
obtain  an automated counting of the pixel wise percentage
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contribution of high, medium and low positive pix-
els/intensity in an image, i.e. the number of pixels of
a  speciﬁc intensity value vs. their respective intensity
zone. For measurement of BPDE-DNA adducts [simi-
lar  areas of tissue sections (mm2) and number of cells
(∼800 cells/section/animal)], total intensity (%) [of nuclei
containing percentage of high, medium and low intensity]
was  analyzed within different treatment groups. How-
ever,  apoptosis was measured in terms of total apoptotic
nuclei intensity as well as percentage of apoptotic posi-
tive  and negative cells in similar areas of tissue sections
(mm2) and number of cells (∼800 cells/section/animal) in
different  treatment groups. In this method, pixel intensi-
ties  were categorized into 4 zone(s) with pixel intensity
value ranging from 0 to 60 for a score value of high posi-
tive  (3+), 61–120 for medium positive (2+), and 121–170
for low positive (1+). Pixel values beyond 170 were empir-
ically  analyzed and were found to be negative (0, blue
stained nuclei) cells. After determining these numbers,
the program applied them to a simple algebraic for-
mula as shown below to determine the actual number of
high/medium/low positive intensity.
Percentage of high positive/medium positive/low positive i
= Percentage of high positive/medium positive/low posi
Total number of pixe
In order to determine the total percentage intensity (of
adducts containing nuclei and/or apoptotic nuclei), the fol-
lowing  formula was used.
Total percentage of intensity (Adduct containing cells/Apop
=  Percentage of (high positive intensity + medium positiv
Quantitative analysis was performed in photomicro-
graphs of 10 randomly selected ﬁelds per section with
at  least three mice per group. More than 800 cells were
counted per section.
2.6.  Terminal deoxynucleotidyl transferase biotin-dUTP
nick end labeling (TUNEL) assay
Apoptosis was assayed in formalin-ﬁxed, parafﬁn
embedded 5 m tissue sections employing in situ TUNEL
assay kit (Promega, Madison, WI,  USA) according to the
manufacturer’s instructions. The nuclei of the apoptotic
cells were stained brown in color. Levels of apopto-
sis/apoptotic index were computed in two ways: (1)
quantitative comparison of the images (magniﬁcation
×400) in terms of percentage intensity was done by mod-
iﬁed  digital image analysis protocols as described above
and  (2) by counting the number of positively stained
cells × 100/total number of cells in the photomicrographs
of tissue sections (without taking into account the color
intensity) in the same image by using cell counter plug-in of
Image  J 1.43 (NIH) software [15], of at least 10 different ran-
domly  selected ﬁelds per section with at least three mice
per  group. More than 800 cells were counted per section.rts 1 (2014) 1181–1194
ty
B color intensity pixels × Score of the zone
e image
uclei)
nsity + low positive intensity)
2.7.  Statistical analysis
Densitometry and quantitative analysis of images were
performed using Image J 1.43 (NIH) software. Statistical
analysis was  performed using SPSS 15.0 software (IBM, Inc.,
Chicago,  IL, USA) and STATA 12 software (StataCorp, TX,
USA).  Data are presented as mean ± SE. Means of (western
blot analysis) data were compared using ANOVA with post
hoc  testing. Statistical comparisons of levels of BPDE-DNA
adducts and TUNEL positivity among the groups were made
using  Poisson regression, which is speciﬁc for data repre-
senting counts or number of events and can handle cases
in  which few or no events occur. A p ≤ 0.05 was considered
statistically signiﬁcant.
3.  Results
Based on the net body weight gain and histopathological
evaluation of tissues, no toxicity or mortality was observed
in  animals belonging to the various treatment groups
during the experimental period (Supplementary Figs. 1
and  2).
Supplementary Figs. 1 and 2 related to this article can
be  found, in the online version, at doi:10.1016/j.toxrep.
2014.11.008.
3.1. Effect of dietary curcumin post-treatment on
disappearance of BPDE-DNA adducts in mouse tissues
3.1.1. Measurement of BPDE-DNA adducts at 24, 72 and
120  h
In  animals receiving vehicle [V(+24 h), V(+48 h), V(+96 h),
V(+144 h)] or vehicle + curcumin [V(+48 h) + C 24 h, V(+96 h) + C
72 h, V(+144 h) + C 120 h]-treated subgroups, BPDE-DNA
adducts were not detected in liver and lungs of mice, while
detectable levels of BPDE-DNA adduct(s) were observed
by  IHC staining following 24 h of B(a)P administration in
these  tissues [subgroup BP(+24 h), maintained on standard
laboratory diet] (Fig. 2A and B) as reported [7,12], sug-
gesting speciﬁcity of reagent (antibody) and demonstrating
a  major difference in the levels of BPDE-DNA adducts
between exposed and non-exposed animals/tissues. Lev-
els  of BPDE-DNA adducts were measured in a similar
area of tissue sections (mm2) and number of cells (∼800
cells/section/animal) in terms of total adduct intensity as
well  as nuclei containing a percentage of high, medium and
low  intensity due to BPDE-DNA adducts. It was observed
that with passage of time, mice on the control diet for 24, 72
G. Kumar et al. / Toxicology Reports 1 (2014) 1181–1194 1185
Fig. 2. Effect of curcumin post-treatment on levels of BPDE-DNA adducts in mouse tissues (experiments 1 and 2). Levels of BPDE-DNA adducts were
measured  by immunohistochemical detection in parafﬁn-embedded tissue sections of mouse (A) liver at 24, 72 and 120 h, (B) lungs at 24, 72 and 120 h, (C)
liver  at 7, 14 and 28 days, and (D) lungs at 7, 14 and 28 days; using a monoclonal antibody speciﬁcally recognizing BPDE-DNA adducts. Results are presented
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Bs  representative photomicrographs at magniﬁcation ×400. Quantitative
epresent  mean ± SE of three observations. Statistical analysis was  perfo
hen  compared to BP(+24 h) subgroup; ‘#’ signiﬁcant when compared to re
nd 120 h [subgroups BP(+48 h), BP(+96 h), BP(+144 h)] showed
 time-related signiﬁcant decrease in total adduct(s) inten-
ity  (levels) in the liver and lungs compared to BP(+24 h) and
ubgroup of preceding time point (Figs. 2A, B and 3A, B).
nterestingly, mice that were shifted to 0.05% curcumin
iet and killed at 24, 72 and 120 h [subgroups BP(+48 h) + C
4  h, BP(+96 h) + C 72 h, BP(+144 h) + C 120 h] showed signiﬁ-
antly higher decrease in the levels of adducts (intensity)
n  the liver and lungs compared to BP(+24 h) and respec-
ive time-matched controls [subgroups BP(+48 h), BP(+96 h),
P(+144 h)] (Figs. 2A, B and 3A, B). This decrease wass was  done by digital image analysis as described under Section 2. Data
sing STATA 12 software using Poisson regression analysis. ‘*’ signiﬁcant
e time-matched controls.
also evident when a comparison of percentage inten-
sity of nuclei containing high, medium and low levels of
adducts  was  made between curcumin-treated and respec-
tive  time-matched controls. In the liver, the observed
decrease in total adduct intensity in B(a)P [BP(+48 h),
BP(+96 h), BP(+144 h)] and B(a)P + curcumin [BP(+48 h) + C 24 h,
BP(+96 h) + C 72 h, BP(+144 h) + C 120 h]-treated subgroups
appears to be attributed to the reduction in percentage
intensity of nuclei containing high and medium levels of
adducts.  In the lungs, it was  due to decrease in nuclei
containing high levels of adducts both in B(a)P [BP(+48 h),
1186 G. Kumar et al. / Toxicology Reports 1 (2014) 1181–1194
 mouse Fig. 3. Levels of BPDE-DNA adducts in
BP(+96 h), BP(+144 h)] and B(a)P + curcumin [BP(+48 h) + C 24 h,
BP(+96 h) + C 72 h, BP(+144 h) + C 120 h]-treated subgroups
(Fig. 2A and B). Notably, the percentage intensity of nuclei
containing low levels of adducts remained similar in all
the  subgroups, i.e. animals given B(a)P [BP(+24 h), BP(+48 h),
BP(+96 h), BP(+144 h)] and B(a)P + curcumin [BP(+48 h) + C 24 h,
BP(+96 h) + C 72 h, BP(+144 h) + C 120 h]-treated subgroups
(Fig. 2A and B). Together, results suggest that dietary cur-
cumin  led to enhancement of decrease in nuclei containing
high and medium levels of adducts in the liver whereas
in  the lungs a curcumin-mediated enhanced decrease
was mainly observed in nuclei containing high levels of
adduct(s).
3.1.2.  Measurement of BPDE-DNA adducts at 7, 14 and
28  days
As observed in experiment 1, levels of BPDE-DNA
adducts were not detected in vehicle [V(+24 h), V(+8 d),
V(+15 d), V(+29 d)] or vehicle + curcumin [V(+8 d) + C 7 d,
V(+15 d) + C 14 d, V(+29 d) + C 28 d]-treated subgroups in liver
and lungs of mice while detectable levels of BPDE-DNA
adducts were observed (stained nuclei) following 24 h
of  single dose of B(a)P in the liver and lungs of mice
(Fig. 2C and D). Signiﬁcant differences were not observed
in  subgroups [V(+24 h) and BP(+24 h)] in two different sets of
experiments conducted at different times. As observed in
experiment 1, mice on the control diet for 7, 14 and 28
days  [subgroups BP(+8 d), BP(+15 d), BP(+29 d)] showed a time-
related signiﬁcant decrease in total adduct levels as seen
by  adduct intensity in the liver and lungs of mice com-
pared to BP(+24 h) and subgroup of preceding time point.liver and lungs (experiments 1 and 2).
Interestingly, mice that were shifted to 0.05% curcumin
diet and killed at 7, 14 and 28 days [subgroups BP(+8 d) + C
7  d, BP(+15 d) + C 14 d, BP(+29 d) + C 28 d] showed a signiﬁ-
cantly higher decrease in total levels of adduct intensity
in  the liver and lungs compared to BP(+24 h) and respec-
tive time-matched controls [subgroups BP(+8 d), BP(+15 d),
BP(+29 d)] (Figs. 2C, D and 3C, 3D). This decrease was also
evident when comparison of the percentage intensity of
nuclei  containing high, medium and low levels of adducts
was  made between curcumin-treated and time-matched
controls. In the liver, the observed decrease in total adduct
intensity appears to be attributed to reduction in percent-
age  intensity of nuclei containing high and low levels of
adducts. However, in lungs, it was  mainly due to a decrease
in  intensity of nuclei containing high levels of adducts in
mice  shifted to 0.05% curcumin diet and killed at 7, 14
and  28 days [subgroups BP(+8 d) + C 7 d, BP(+15 d) + C 14 d,
BP(+29 d) + C 28 d] compared to BP(+24 h) and respective time-
matched controls [subgroups BP(+8 d), BP(+15 d), BP(+29 d)]
(Fig. 2C and D). These results suggest that dietary curcumin
further enhanced the decrease in total adduct intensity in
the  liver and lungs of mice although the extent of decrease
varied.
3.2.  Effect of dietary curcumin post-treatment on
apoptosis in mouse tissues3.2.1.  Measurement of apoptotic index at 24, 72 and
120 h
The  observed decrease in levels of BPDE-DNA adducts
in  liver and lungs may  be attributed to increased loss
G. Kumar et al. / Toxicology Reports 1 (2014) 1181–1194 1187
Fig. 4. Effect of curcumin post-treatment on apoptosis/apoptotic index in B(a)P-treated mice (experiments 1 and 2). Levels of cell turn-over or extent of
apoptosis  was  analyzed by TUNEL assay in parafﬁn-embedded tissue sections of mouse (A) liver at 24, 72 and 120 h, (B) lungs at 24, 72 and 120 h, (C) liver
at  7, 14 and 28 days, and (D) lungs at 7, 14 and 28 days. Results are presented as representative photomicrographs at magniﬁcation ×400. Quantitative
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sing  STATA 12 software using Poisson regression analysis. ‘*’ signiﬁcant w
ime-matched controls.
f adducts containing cells and/or enhanced DNA repair
nd/or dilution of adducted DNA by newly synthesized
on-adducted DNA. To investigate the effect of dietary
urcumin post-treatment on B(a)P-induced cell turnover
n  mouse liver and lungs, TUNEL assay was employed.
urnover of cells by apoptosis in the liver and lungs was
easured in a similar area of tissue sections (mm2) and
umber of cells (∼800 cells/section/animal). Apoptotic
ndex was measured in terms of total apoptotic nucleiresent mean ± SE of ﬁve observations. Statistical analysis was performed
mpared to BP(+24 h) subgroup; ‘#’ signiﬁcant when compared to respective
intensity as well as the percentage of apoptotic posi-
tive and negative cells. Notably, 5–10% and 20–35% of
total apoptotic nuclei were detected in the liver and lung
tissues  of vehicle [V(+24 h), V(+48 h), V(+96 h), V(+144 h)] or vehi-
cle + curcumin [V(+48 h) + C 24 h, V(+96 h) + C 72 h, V(+144 h) + C
120 h]-treated subgroups, respectively (Fig. 4A and B).
Compared to the vehicle treated group (V group), a sig-
niﬁcant increase in the percentage of positive cells/the
percentage intensity of the total apoptotic nuclei was
1188 G. Kumar et al. / Toxicology Reports 1 (2014) 1181–1194
se liver Fig. 5. Levels of apoptosis in mou
observed following 24 h of single dose of B(a)P [subgroup
BP(+24 h)] in liver whereas in the lungs, it was similar to the
vehicle treated group (Fig. 4A and B). It was observed that
compared to subgroup BP(+24 h), mice on control diet for
24,  72 and 120 h [subgroups BP(+48 h), BP(+96 h), BP(+144 h)]
showed an increase in apoptotic cells as judged by the
percentage of TUNEL positive apoptotic cells (apoptotic
index) and/or the percentage intensity of total apoptotic
nuclei in the liver and lungs of mice. Interestingly, mice
that  were shifted to the 0.05% curcumin diet and killed at 72
and  120 h [subgroups BP(+96 h) + C 72 h, BP(+144 h) + C 120 h]
showed further increase in B(a)P-mediated apoptosis as
seen  by an increase in numbers of apoptotic cells as well
as  the percentage intensity of total apoptotic nuclei com-
pared  to BP(+24 h) and respective time-matched controls
[subgroups BP(+96 h) and BP(+144 h)] (Figs. 4A, B and 5A, B).
These observations thus suggest that dietary curcumin fur-
ther  enhances the B(a)P-induced apoptosis, which would
indirectly confer protection due to increased removal of
adduct  containing cells.
3.2.2. Measurement of apoptotic index at 7, 14 and 28
days
As  observed in experiment 1, 5–10% and 20–35% of
total apoptotic cells (apoptotic index) were detected in
the  liver and lung tissues of vehicle [V(+24 h), V(+8 d),
V(+15 d), V(+29 d)] or vehicle + curcumin [V(+8 d) + C 7 d,
V(+15 d) + C 14 d, V(+29 d) + C 28 d]-treated subgroup, respec-
tively (Fig. 4C and D). It was observed that compared to
subgroup BP(+24 h), mice on the control diet for 7 days [sub-
group BP(+8 d)] showed an increase in apoptosis as judgedand lungs (experiments 1 and 2).
by  an increased percentage of positive cells (apoptotic
index) and/or the percentage intensity of total apoptotic
nuclei in the liver and lungs of mice whereas a relative
decrease in apoptosis in the liver was observed in mice on
the  control diet for 14 and 28 days [subgroups BP(+15 d),
BP(+29 d)] (Figs. 4C, D and 5C, D). Interestingly, mice that
were shifted to the 0.05% curcumin diet and killed at 7, 14
and  28 days did not show signiﬁcant difference in the level
of  apoptosis in the liver and lungs of mice compared to
BP(+24 h) and respective time-matched controls [subgroups
BP(+8 d), BP(+15 d), BP(+29 d)]. However at 8 days, the liver of
mice showed a decrease in the percentage of positive apop-
totic  cells (apoptotic index) and/or the percentage intensity
of  total apoptotic nuclei (Figs. 4C, D and 5C, D). An observed
decrease in DNA adducts without enhancement in the lev-
els  of apoptosis in the liver and lungs suggests a role of DNA
repair  and/or dilution of BPDE-DNA adducts in tissue cells.
3.2.3.  Measurement of apoptosis-related markers at 24,
72  and 120 h
Further, to conﬁrm and compliment the post-treatment
effects of dietary curcumin in enhancement of apoptosis
measured by TUNEL assay, protein levels of apoptosis-
related markers were analyzed in the liver and lungs of
mice  by immunoblotting. Notably, the levels of apopto-
sis  markers (Bax, Bcl-2 and caspase-3) remained similar
in  vehicle [V(+24 h), V(+48 h), V(+96 h), V(+144 h)] or vehi-
cle + curcumin [V(+48 h) + C 24 h, V(+96 h) + C 72 h, V(+144 h) + C
120 h]-treated subgroups in the liver and lungs of mice
(Fig.  6A and C). No change in levels of apoptosis mark-
ers  (Bax, Bcl-2 and caspase-3) was  observed following
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Fig. 6. Effect of curcumin post-treatment on apoptosis-related biochemical markers in B(a)P-treated mice (experiments 1 and 2). Representative blot and
relative  levels of Bax, Bcl-2 and Caspase-3 protein were measured in total cell lysates prepared from mouse (A) liver at 24, 72 and 120 h, and (C) lungs
at  24, 72 and 120 h, (E) liver at 7, 14 and 28 days, and (G) lungs at 7, 14 and 28 days analyzed by immunoblotting using speciﬁc antibodies. -actin was
used  as the loading control. Extent of apoptosis was determined by calculating the ratio of normalized band intensity of Bax and Bcl-2 in (B) liver at 24,
72  and 120 h, (D) lungs at 24, 72 and 120 h, (F) liver at 7, 14 and 28 days, and (H) lungs at 7, 14 and 28 days of mice. Data represent mean ± SE of three
observations. ‘*’ signiﬁcant when compared to BP(+24 h) subgroup; ‘#’ signiﬁcant when compared to respective time-matched controls (p ≤ 0.5, ANOVA
followed  by Bonferroni’s test, p ≤ 0.05).
gy Repo1190 G. Kumar et al. / Toxicolo
24 h of a single dose of B(a)P [subgroup BP(+24 h)] in liver
and lungs compared to vehicle treated group (V group).
In  comparison with subgroup BP(+24 h), mice on the con-
trol diet for 24, 72 and 120 h [subgroups BP(+48 h), BP(+96 h),
BP(+144 h)] showed signiﬁcant increase in the protein level
of  Bax in the liver (72 and 120 h) and lungs (120 h).
Mice shifted to 0.05% curcumin diet [subgroups BP(+48 h) + C
24  h, BP(+96 h) + C 72 h, BP(+144 h) + C 120 h] showed a sig-
niﬁcant increase in the protein level of Bax in the liver
(72  and 120 h) and lungs (24 and 120 h) compared to
BP(+24 h) and respective time-matched controls (Fig. 6A
and  C). Concurrent to this, the protein level of Bcl-2 pro-
tein  was unaltered in mice on the control diet [subgroups
BP(+48 h), BP(+96 h), BP(+144 h)] compared to BP(+24 h). Impor-
tantly, mice that were shifted to 0.05% curcumin diet
[subgroups BP(+48 h) + C 24 h, BP(+96 h) + C 72 h, BP(+144 h) + C
120 h] showed a decrease in the level of Bcl-2 in the liver
(72  and 120 h) and lungs (120 h) compared to BP(+24 h) and
respective time-matched controls (Fig. 6A and C). These
observations together account for the progressive incre-
ment  seen in the Bax/Bcl-2 ratio upon dietary curcumin
post-treatment and thereby indicates that post-treatment
with curcumin further enhances the apoptosis in B(a)P-
treated mice (Fig. 6B and D). In addition, signiﬁcant increase
was  also observed in the protein level of caspase-3 (the
death  executioner) at 72 and 120 h in the liver and at 120 h
in  the lungs of mice shifted to curcumin diet compared
to respective time-matched controls (Fig. 6A and C). This
correlates well with the enhancement observed in apop-
totic  index as well as in Bax/Bcl-2 ratio upon curcumin
treatment. Overall, these results suggest that curcumin-
mediated enhanced apoptosis in B(a)P-treated mice could
be  one of the plausible reasons contributing toward the
decrease in BPDE-DNA adducts in liver and lungs of mice.
3.2.4.  Measurement of apoptosis-related markers at 7, 14
and  28 days
Further, to conﬁrm post-treatment effects of dietary
curcumin on apoptosis measured by TUNEL assay, protein
levels  of apoptosis-related markers were analyzed in the
liver  and lungs of mice by immunoblotting. As observed
in experiment 1, levels of apoptosis markers (Bax, Bcl-
2  and Caspase-3) remained similar in vehicle [V(+24 h),
V(+8 d), V(+15 d), V(+29 d)] or vehicle + curcumin [V(+8 d) + C 7 d,
V(+15 d) + C 14 d, V(+29 d) + C 28 d]-treated subgroups in the
liver and lungs of mice (Fig. 6E and G). No change in the
levels  of apoptosis markers (Bax, Bcl-2 and caspase-3) was
observed  in the liver and lungs of mice on the control diet
for  8, 15 and 29 days [subgroups BP(+8 d), BP(+15 d), BP(+29 d)]
compared to BP(+24 h). Mice shifted to 0.05% curcumin
diet [subgroups BP(+8 d) + C 7 d, BP(+15 d) + C 14 d, BP(+29 d) + C
28 d] showed signiﬁcant increase in the level of Bax protein
in  the liver (14 and 28 days) and lungs (28 d) compared to
respective time-matched controls (Fig. 6E–H). Levels of Bcl-
2  were similar in the liver of mice shifted to 0.05% curcumin
diet  [subgroups BP(+8 d) + C 7 d, BP(+15 d) + C 14 d, BP(+29 d) + C
28 d] compared to BP(+24 h) and respective time-matched
controls whereas decrease was observed in the lungs (14
and  28 days) of mice shifted to curcumin diet compared
to  BP(+24 h) and respective time-matched controls (Fig. 6E
and  F). In addition, signiﬁcant increase was noticed in therts 1 (2014) 1181–1194
protein  expression of caspase-3, the death executioner, at
14  and 28 days in the liver and at 28 days in the lungs of
mice  shifted to curcumin diet compared to BP(+24 h) and
respective time-matched controls. Observed decrease in
DNA  adducts without enhancement in levels of apoptosis
in  liver and lungs suggest role of DNA repair and/or dilution
of  BPDE-DNA adducts in tissue cells.
3.3. Effect of dietary curcumin post-treatment on levels
of  cell proliferation markers in mouse tissues
3.3.1. Measurement of cell proliferation markers at 24,
72  and 120 h
In addition to the role of apoptosis in disappearance
of BPDE-DNA adducts, contribution of dilution of adduct
containing DNA by newly synthesized non-adducted DNA,
protein  levels of cell proliferation markers such as PCNA
in  mouse liver and lungs were analyzed and compared
by immunoblotting analysis. Levels of PCNA remained
similar in vehicle [V(+24 h), V(+48 h), V(+96 h), V(+144 h)] or vehi-
cle + curcumin [V(+48 h) + C 24 h, V(+96 h) + C 72 h, V(+144 h) + C
120 h]-treated subgroups in the liver and lungs of mice
(Figs. 7A, B and 8A, B). Similarly, no signiﬁcant change in the
levels  of PCNA was observed following 24 h of single dose
of  B(a)P [subgroup BP(+24 h)] in liver and lungs compared
to vehicle treated group (V group) (Figs. 7A, B and 8A, B).
Furthermore, mice on the control diet [subgroups BP(+48 h),
BP(+96 h), BP(+144 h)] showed an increase in the levels of
PCNA in the liver and lungs compared to subgroup BP(+24 h)
except in the liver at 48 h. Interestingly, mice that were
shifted to 0.05% curcumin diet [subgroups BP(+48 h) + C 24 h,
BP(+96 h) + C 72 h, BP(+144 h) + C 120 h] showed signiﬁcant
decrease in the levels of PCNA in the liver (72 and 120 h)
and  lungs (120 h) compared to respective time-matched
controls (Figs. 7A, B and 8A, B). As observed in the case of
PCNA,  a similar trend was observed in the levels of cyclin D1
wherein  a signiﬁcant curcumin-mediated decrease in the
cyclin  D1 level was  observed in lungs of mice compared to
respective  time-matched controls (Fig. 7B).
3.3.2. Measurement of cell proliferation markers at 7, 14
and  28 days
Similar comparative evaluations of cell proliferation
markers were undertaken in the liver and lungs of mice at
7,  14 and 28 days. As analyzed in experiment 1, prolifera-
tion was  assessed by comparing levels of PCNA. As observed
in  experiment 1, levels of PCNA remained similar in vehi-
cle  [V(+24 h), V(+8 d), V(+15 d), V(+29 d)] or vehicle + curcumin
[V(+8 d) + C 7 d, V(+15 d) + C 14 d, V(+29 d) + C 28 d]-treated sub-
groups in the liver and lungs of mice (Figs. 7C, D and 8C, D).
No  change in the level of PCNA was observed in the liver
and  lungs of mice on control diet for 8, 15 and 29 days [sub-
groups  BP(+8 d), BP(+15 d), BP(+29 d)] compared to BP(+24 h).
Interestingly, mice that were shifted to 0.05% curcumin
diet [subgroups BP(+8 d) + C 7 d, BP(+15 d) + C 14 d, BP(+29 d) + C
28 d] showed an increase in the levels of PCNA in the
liver (7 and 28 days) and lungs (14 and 28 days) com-
pared to BP(+24 h) and respective time-matched controls
(Figs. 7C, D and 8C, D).
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Fig. 7. Effect of curcumin post-treatment on cell proliferation markers in B(a)P-treated mice (experiments 1 and 2). Representative blot and relative levels
of  (A) PCNA in liver at 24, 72 and 120 h, (B) PCNA and Cyclin D1 in lungs at 24, 72 and 120 h, (C) PCNA in liver at 7, 14 and 28 days, and (D) PCNA in lungs
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. Discussion
Exposure to complex mixtures of PAH, which have
een implicated in inducing skin, lung and breast can-
er,  is unavoidable. PAH-induced carcinogenesis involves
 number of steps including: (i) the enzymatic activation
f  the PAH into metabolites, (ii) the covalent binding of
he  PAH metabolites to DNA, and (iii) the induction of
utations that serve to initiate the transformation pro-
ess  as a result of PAH-DNA adducts. Levels of DNA adducts
easured at any point in time reﬂect tissue-speciﬁcates of adducts formation and removal, which in turn,
epends upon carcinogen activation/detoxiﬁcation, DNA
epair,  adduct instability, tissue turnover, etc. The concept
hat  cancer can be prevented or that certain diet-derived as analyzed by immunoblotting using speciﬁc antibodies, respectively.
ations. ‘*’ signiﬁcant when compared to BP(+24 h) subgroup; ‘#’ signiﬁcant
y Bonferroni’s test, p ≤ 0.05).
substances can postpone its onset is receiving increasing
attention [17,18]. Turmeric/curcumin pre-treatment has
been  demonstrated to decrease the formation of BPDE-
DNA  adducts in tissues of mice/rats as a result of a
decrease in B(a)P-induced phase I enzymes and/or induc-
tion  of phase II enzymes [7,12]. In several studies curcumin
post-treatment has been shown to decrease multiplicity
of carcinogen-induced tumor formation in experimental
models such as B(a)P-induced forestomach tumors, NDEA-
induced  hepatocarcinogenesis, DMBA-induced mammary
tumorigenesis, AOM-induced colon tumors, etc. [10,11,19].
Even  after exposure to carcinogen, a decrease in tumor
multiplicity due to exposure to turmeric/curcumin was
observed and is likely to be due to the decrease in cell pro-
liferation and/or loss of initiated/DNA adduct containing
1192 G. Kumar et al. / Toxicology Reports 1 (2014) 1181–1194
use liveFig. 8. Levels of proliferation in mo
cells. To understand the post-treatment effect of curcumin
on  disappearance of BPDE-DNA adducts, levels of BPDE-
DNA  adducts were measured at various time intervals in
the  liver and lungs of mice after allowing the formation
of equal/similar levels of adducts and then exposing the
animals  to dietary curcumin. Levels of BPDE-DNA adducts
were  measured in tissue sections by IHC staining wherein
an  adduct-speciﬁc antibody was employed and levels were
quantitated by measuring the adduct-intensity employing
image analyses based on a principle adopted for analyzing
nuclear staining typical for a DNA adduct staining pat-
tern  [16]. Although the method employed for quantitation
of  BPDE-DNA adducts does not provide absolute levels of
DNA  adducts per unit weight of DNA or deﬁned number
of  normal nucleotides, it is capable of unbiased stratiﬁca-
tion and allows for relative comparison of adduct levels
per  equal area and/or similar number of cells. This non-
destructive measurement method provides localization of
adducts  within cells in reasonable time and cost and multi-
ple  samples can be processed in a batch employing deﬁned
conditions.
Absence of BPDE-DNA adducts were observed in tis-
sue  sections from liver and lungs of mice receiving vehicle
or  dietary curcumin whereas signiﬁcant as well as mea-
surable levels of BPDE-DNA adducts were observed in
these  tissues following 24 h of B(a)P administration as
reported in mouse skin, liver and lungs [7,20,21]. The time-
dependent [BP(+48 h), BP(+96 h), BP(+144 h)/BP(+8 d), BP(+15 d),
BP(+29 d)] decrease in the levels of BPDE-DNA adducts in
the  liver and lungs compared to BP(+24 h) following ther and lungs (experiments 1 and 2).
single dose of carcinogen exposure was  similar to that
observed by others investigators in mouse/rat skin dur-
ing  24 h–28 days [20,22]. The time-related decrease in the
levels  of DNA adducts was  relatively higher in the liver
than  the lungs compared to BP(+24 h). Our results clearly
demonstrate that dietary curcumin (0.05%) post-treatment
[subgroups BP(+48 h) + C 24 h, BP(+96 h) + C 72 h, BP(+144 h) + C
120 h and BP(+8 d) + C 7 d, BP(+15 d) + C 14 d, BP(+29 d) + C 28 d
in experiments 1 and 2, respectively] further enhanced
the decrease in the levels of BPDE-DNA adducts both in
the  liver and lungs at 48–144 h (experiment 1) and 8–28
days (experiment 2) compared to BP(+24 h) and respec-
tive time-matched controls [subgroups BP(+48 h), BP(+96 h),
BP(+144 h) and BP(+8 d), BP(+15 d), BP(+29 d) in experiments 1
and 2, respectively]. In the present study the observation
of high levels of BPDE-DNA adducts at 24 h after the car-
cinogen treatment and sharp decreases within 1 wk (∼8
days)  is also in agreement with observations reported on
mouse/rat skin [22]. The probable reasons for the observed
time-related decrease in the levels of BPDE-DNA adducts
in  the liver and lungs could be due to loss or turnover of
DNA  adduct containing cells and/or repair of carcinogen-
DNA adducts and/or dilution of adducted DNA with newly
synthesized non-adducted DNA. The observed curcumin-
mediated enhancement in the disappearance of BPDE-DNA
adducts is likely to be due to modulation of one or more
of  the aforementioned processes. Analyses conducted to
identify  the reasons for curcumin-mediated enhanced dis-
appearance of BPDE-DNA adducts showed that basal levels
of  apoptosis/turnover in the control liver (5–10%) and
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ungs (20–35%) were signiﬁcantly enhanced by a single
ose of B(a)P only in the liver (17–24%) but not in the
ungs (32–38%). Subsequently, a time-related increase in
he  percentage apoptosis was observed in both the tissues,
subgroups BP(+48 h), BP(+96 h), BP(+144 h); 32–56%) and these
ates or levels were further enhanced in B(a)P-treated ani-
als  exposed to dietary curcumin [subgroups BP(+48 h) + C
4  h, BP(+96 h) + C 72 h, BP(+144 h) + C 120 h; 37–73%] com-
ared to BP(+24 h) and respective time-matched controls
subgroups BP(+96 h) and BP(+144 h)]. Apoptosis measured
mploying semi-quantitative and quantitative assays, and
arameters  showed good agreement in direction and
xtent of change that appears to be one of the major
ontributors in disappearance of BPDE-DNA adducts in
issues  studied. Quantitative analysis and comparison of
HC  staining measuring BPDE-DNA adducts and apopto-
is  in tissue sections have the advantage that preceding
r subsequent parafﬁn-embedded sections from the same
ortion  of the tissue are compared, and this comparison is
ikely  to be relevant and meaningful. Curcumin-mediated
nhancement of apoptosis in B(a)P-treated (normal liver
nd  lung tissues) cells has some similarity with its effects
n  terms of apoptosis observed in transformed or immortal-
zed  cells in culture [23–25]. To the best of our knowledge,
his is an initial in vivo report demonstrating that dietary
urcumin augmented the expression of caspase-3 and
ncreased the Bax/Bcl-2 ratio and apoptotic index in nor-
al  cells in response to B(a)P-induced DNA damage. This in
urn  probably accounts for the enhanced disappearance of
dduct  containing nuclei although the degree of responses
aried.
The  other potential contributor in observed relative
ecrease in BPDE-DNA adducts is cell proliferation, and its
ole  was assessed by comparing the levels of PCNA by west-
rn  blot analysis. It was seen from experiment 1 that levels
f  PCNA were enhanced post B(a)P-treatment especially
t  later time points [subgroups BP(+96 h) and BP(+144 h)],
nd B(a)P-mediated increases were signiﬁcantly decreased
y  dietary curcumin when compared to time-matched
(a)P-treated controls in liver [subgroups BP(+96 h) + C 72 h,
P(+144 h) + C 120 h] and lungs [BP(+144 h) + C 120 h]. In exper-
ment 2, levels of PCNA were not altered signiﬁcantly at
–28  days post B(a)P [BP(+8 d), BP(+15 d), BP(+29 d)] both in the
iver and lungs while curcumin treatment resulted in sig-
iﬁcant  increase in the levels of PCNA in liver [subgroups
P(+8 d) + C 7 d, BP(+29 d) + C 28 d] and lungs [BP(+15 d) + C 14 d,
P(+29 d) + C 28 d]. It may  be noted that exposure to dietary
urcumin alone does not alter the levels of PCNA in liver
nd  lungs of mice.
After  considering and comparing the slope of time-
elated and curcumin-mediated changes in BPDE-DNA
dducts and numbers of cells undergoing apoptosis and
ell  proliferation, it is seen that the observed decrease in
PDE-DNA adducts in experiment 1 is mainly attributed
o  curcumin-mediated enhanced apoptosis. In experiment
 dilution of BPDE-DNA adducts by newly synthesized
on-adducted DNA due to cell proliferation appears to be
he  reason (Figs. 3, 5 and 8). In both these experiments,
poptosis (experiment 1) and cell proliferation (experi-
ent 2) alone may  not be sufﬁcient to result in the extent
f  decrease as potential contribution of DNA-repair mayrts 1 (2014) 1181–1194 1193
also  be included. Although potential contribution if any,
of  DNA-repair in curcumin-mediated enhanced disappear-
ance  of BPDE-DNA adducts has not been studied/ruled out
(in  terms of activity and/or protein levels of DNA repair
enzymes) in our study, this shortcoming does not dimin-
ish  the importance of the convincing evidence presented
on  enhanced disappearance of BPDE-DNA adducts due to
enhanced  apoptosis and/or cell proliferation.
In conclusion, the present study suggested that cur-
cumin post-treatment augments B(a)P-induced apoptosis,
and  this eventually resulted in increased loss of adducts
containing cells in mice evaluated at 24–120 h, suggesting
the role of apoptosis in removal of adduct containing cells.
Curcumin-mediated enhanced loss in BPDE-DNA adduct
containing cells probably results in reduction in the num-
bers  of initiated cells in respective tissues, and this, along
with  curcumin-mediated inhibition of cell proliferation in
these  tissues leads to decrease in tumor multiplicity/tumor
area/volume.
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